Lincomycin

Spécifications

154-21-2Numéro CAS

205-824-6Numéro CE

(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamideNom IUPAC

C18H34N2O6SFormule chimique

406.5 g/molMasse molaire

lincomycin; 154-21-2; Cillimycin; Lincolnensin; Lincomicina; Lincomycinum; Jiemycin; Lincomycin A; Lincolcina; BOD072YW0F; U-10149; U 10,149A; U-10,149; CHEBI:6472; DTXSID3023215; (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide; Methyl 6,8-dideoxy-6-trans-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside; (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide; D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-; (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl)propyl)-1-methyl-4-propyl-pyrrolidine-2-carboxamide; (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide; METHYL 6,8-DIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYLPYRROLIDIN-2-YL)CARBONYL)AMINO)-1-THIO-D-ERYTHRO-alpha-D-GALACTO-OCTOPYRANOSIDE; methyl 6,8-dideoxy-6-({[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl}amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside; LincoMed 300; RefChem:55509; Lincomycin Injectable 30%; Lincomycin Injectable, USP; DTXCID003215; J01FF02; LINCOMIX 20, LINCOMIX 50; Hemihydrate Lincomycin Monohydrochloride; LINCOMYCIN 100, LINCOMYCIN 25, LINCOMYCIN 300; 205-824-6; Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-D-erythro-D-galacto-octopyranoside (alpha-; Lincocin; Lincomycin (USAN/INN); CHEMBL1447; Frademicina; (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide; Lincomycin (hydrochloride); C18H34N2O6S; LCM; Lincomycine [French]; NSC 70731; U10149A; AC1MHD7X; Lincomycine [INN-French]; Lincomycinum [INN-Latin]; UNII-BOD072YW0F; Lincomicina [INN-Spanish]; Bactramycin; Lincorex; Lincomycin [USAN:INN:BAN]; Lincomycin, (2S-cis)-Isomer; HSDB 3109; L-Mycin; 3QB; methyl 6,8-dideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-erythro-alpha-D-galacto-octopyranoside; EINECS 205-824-6; BRN 0707677; LINCOMYCIN [MI]; LINCOMYCIN [INN]; LINCOMYCIN [HSDB]; LINCOMYCIN [USAN]; Clindamycin EP Impurity A; LINCOMYCIN [VANDF]; LINCOMYCIN [MART.]; SCHEMBL4010; LINCOMYCIN [WHO-DD]; (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide; orb1708945; LINCOMYCIN [GREEN BOOK]; LINCOMYCIN [ORANGE BOOK]; GTPL10941; LINCOMYCIN [USP IMPURITY]; HMS2089A13; Methyl 6,8-dideoxy-6-trans-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-.alpha.-D-galacto-octopyranoside; BDBM50335522; EBC-13871; MFCD00135816; T1235L; AKOS015951392; AL76787; CCG-208231; DB01627; SMP1_000178; NCGC00159326-11; D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha-; Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-D-erythro-D-galacto-octopyranoside (alpha-form); HY-117660; CS-0066775; NS00000025; C06812; D00223; EN300-118720; AB01275426-01; CLINDAMYCIN HYDROCHLORIDE IMPURITY A [IP]; F608586; Q423428; BRD-K49384696-003-01-9; CLINDAMYCIN PHOSPHATE IMPURITY A [EP IMPURITY]; Z1515385088; CLINDAMYCIN HYDROCHLORIDE IMPURITY A [EP IMPURITY]; (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide; (2S,4R)-N-((1S)-2-hydroxy-1-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide; (2S-TRANS)-METHYL 6,8-DIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE; 1-Methyl-4-propyl-pyrrolidine-2-carboxylic acid [2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide; Clindamycin Phosphate EP Impurity A; Lincomycin(Base); Clindamycin Hydrochloride EP Impurity A; D-Erythro-.alpha.-D-gluco-octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-; D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-; Methyl (5r)-5-[(1r,2r)-2-Hydroxy-1-{[(4r)-1-Methyl-4-Propyl-L-Prolyl]amino}propyl]-1-Thio-Beta-L-Arabinopyranoside; METHYL 6,8-DIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYLPYRROLIDIN-2-YL)CARBONYL)AMINO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDESynonymes